nodes	percent_of_prediction	percent_of_DWPC	metapath
Zileuton—CYP2C9—brain cancer	0.62	1	CbGaD
Zileuton—CYP1A2—Carmustine—brain cancer	0.0716	0.285	CbGbCtD
Zileuton—CYP3A4—Temozolomide—brain cancer	0.0541	0.215	CbGbCtD
Zileuton—PTGS1—Etoposide—brain cancer	0.0475	0.189	CbGbCtD
Zileuton—CYP3A4—Lomustine—brain cancer	0.046	0.183	CbGbCtD
Zileuton—CYP1A2—Etoposide—brain cancer	0.0212	0.0844	CbGbCtD
Zileuton—EPHX2—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.0151	0.211	CbGpPWpGaD
Zileuton—EPHX2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.0136	0.19	CbGpPWpGaD
Zileuton—CYP3A4—Etoposide—brain cancer	0.0111	0.0442	CbGbCtD
Zileuton—Hepatotoxicity—Lomustine—brain cancer	0.00325	0.0582	CcSEcCtD
Zileuton—EPHX2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00314	0.0438	CbGpPWpGaD
Zileuton—Traumatic liver injury—Temozolomide—brain cancer	0.00258	0.0463	CcSEcCtD
Zileuton—PTGS1—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.00198	0.0277	CbGpPWpGaD
Zileuton—ALOX5—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00174	0.0244	CbGpPWpGaD
Zileuton—Hepatotoxicity—Hydroxyurea—brain cancer	0.00159	0.0286	CcSEcCtD
Zileuton—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00147	0.0206	CbGpPWpGaD
Zileuton—PTGS1—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.00137	0.0192	CbGpPWpGaD
Zileuton—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00134	0.0187	CbGpPWpGaD
Zileuton—UGT1A9—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00133	0.0185	CbGpPWpGaD
Zileuton—Hepatotoxicity—Carmustine—brain cancer	0.00129	0.0231	CcSEcCtD
Zileuton—Hepatotoxicity—Temozolomide—brain cancer	0.00125	0.0223	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—GFAP—brain cancer	0.00115	0.0161	CbGpPWpGaD
Zileuton—EPHX2—Metapathway biotransformation—CYP2C9—brain cancer	0.00115	0.0161	CbGpPWpGaD
Zileuton—Liver injury—Temozolomide—brain cancer	0.00114	0.0205	CcSEcCtD
Zileuton—Hyperbilirubinaemia—Temozolomide—brain cancer	0.00106	0.019	CcSEcCtD
Zileuton—Neck pain—Carmustine—brain cancer	0.00101	0.0181	CcSEcCtD
Zileuton—Hepatotoxicity—Etoposide—brain cancer	0.000997	0.0179	CcSEcCtD
Zileuton—Vaginal inflammation—Temozolomide—brain cancer	0.000962	0.0172	CcSEcCtD
Zileuton—Vaginal infection—Temozolomide—brain cancer	0.000908	0.0163	CcSEcCtD
Zileuton—Pain—Carboplatin—brain cancer	0.000874	0.0157	CcSEcCtD
Zileuton—Jaundice—Procarbazine—brain cancer	0.000868	0.0156	CcSEcCtD
Zileuton—Body temperature increased—Carboplatin—brain cancer	0.000808	0.0145	CcSEcCtD
Zileuton—PTGS1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000756	0.0106	CbGpPWpGaD
Zileuton—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000707	0.00988	CbGpPWpGaD
Zileuton—Body temperature increased—Lomustine—brain cancer	0.000707	0.0127	CcSEcCtD
Zileuton—Tension—Procarbazine—brain cancer	0.000683	0.0122	CcSEcCtD
Zileuton—UGT1A9—Irinotecan Pathway—APC—brain cancer	0.000681	0.00952	CbGpPWpGaD
Zileuton—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.00068	0.00951	CbGpPWpGaD
Zileuton—Nervousness—Procarbazine—brain cancer	0.000676	0.0121	CcSEcCtD
Zileuton—LTB4R—GPCR ligand binding—PTCH2—brain cancer	0.000618	0.00863	CbGpPWpGaD
Zileuton—LTB4R—G alpha (q) signalling events—TRPC6—brain cancer	0.000608	0.0085	CbGpPWpGaD
Zileuton—Arthralgia—Procarbazine—brain cancer	0.000592	0.0106	CcSEcCtD
Zileuton—Myalgia—Procarbazine—brain cancer	0.000592	0.0106	CcSEcCtD
Zileuton—Vomiting—Lomustine—brain cancer	0.000569	0.0102	CcSEcCtD
Zileuton—Upper respiratory tract infection—Temozolomide—brain cancer	0.000561	0.0101	CcSEcCtD
Zileuton—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000546	0.00763	CbGpPWpGaD
Zileuton—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	0.000544	0.0076	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—OR4C12—brain cancer	0.000542	0.00757	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—OR14C36—brain cancer	0.000542	0.00757	CbGpPWpGaD
Zileuton—Urinary tract infection—Carmustine—brain cancer	0.000541	0.0097	CcSEcCtD
Zileuton—Nausea—Lomustine—brain cancer	0.000531	0.00952	CcSEcCtD
Zileuton—PTGS1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00053	0.00741	CbGpPWpGaD
Zileuton—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000525	0.00734	CbGpPWpGaD
Zileuton—Urinary tract infection—Temozolomide—brain cancer	0.000523	0.00938	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000517	0.00927	CcSEcCtD
Zileuton—Insomnia—Procarbazine—brain cancer	0.000513	0.0092	CcSEcCtD
Zileuton—Sinusitis—Temozolomide—brain cancer	0.000505	0.00905	CcSEcCtD
Zileuton—Somnolence—Procarbazine—brain cancer	0.000505	0.00905	CcSEcCtD
Zileuton—Ill-defined disorder—Hydroxyurea—brain cancer	0.0005	0.00895	CcSEcCtD
Zileuton—LTB4R—Signaling by GPCR—OR4C12—brain cancer	0.000492	0.00687	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—OR14C36—brain cancer	0.000492	0.00687	CbGpPWpGaD
Zileuton—Malaise—Hydroxyurea—brain cancer	0.000485	0.0087	CcSEcCtD
Zileuton—Constipation—Procarbazine—brain cancer	0.000485	0.0087	CcSEcCtD
Zileuton—Pain—Procarbazine—brain cancer	0.000485	0.0087	CcSEcCtD
Zileuton—Hepatitis—Temozolomide—brain cancer	0.000483	0.00866	CcSEcCtD
Zileuton—Feeling abnormal—Procarbazine—brain cancer	0.000468	0.00838	CcSEcCtD
Zileuton—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000463	0.00647	CbGpPWpGaD
Zileuton—Discomfort—Hydroxyurea—brain cancer	0.000453	0.00812	CcSEcCtD
Zileuton—Urticaria—Procarbazine—brain cancer	0.000451	0.00808	CcSEcCtD
Zileuton—Body temperature increased—Procarbazine—brain cancer	0.000449	0.00804	CcSEcCtD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000448	0.00626	CbGpPWpGaD
Zileuton—LTB4R—Spinal Cord Injury—CDK4—brain cancer	0.000444	0.00621	CbGpPWpGaD
Zileuton—UGT1A9—PPAR Alpha Pathway—CDK4—brain cancer	0.000441	0.00616	CbGpPWpGaD
Zileuton—Jaundice—Etoposide—brain cancer	0.00042	0.00752	CcSEcCtD
Zileuton—Hypersensitivity—Procarbazine—brain cancer	0.000418	0.0075	CcSEcCtD
Zileuton—Pruritus—Procarbazine—brain cancer	0.000402	0.0072	CcSEcCtD
Zileuton—ALOX5—Selenium Micronutrient Network—SOD2—brain cancer	0.000398	0.00556	CbGpPWpGaD
Zileuton—Somnolence—Hydroxyurea—brain cancer	0.000391	0.007	CcSEcCtD
Zileuton—Ill-defined disorder—Temozolomide—brain cancer	0.00039	0.00699	CcSEcCtD
Zileuton—Diarrhoea—Procarbazine—brain cancer	0.000388	0.00696	CcSEcCtD
Zileuton—Dyspepsia—Hydroxyurea—brain cancer	0.000387	0.00693	CcSEcCtD
Zileuton—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000379	0.0068	CcSEcCtD
Zileuton—Malaise—Temozolomide—brain cancer	0.000379	0.0068	CcSEcCtD
Zileuton—Constipation—Hydroxyurea—brain cancer	0.000376	0.00673	CcSEcCtD
Zileuton—Pain—Hydroxyurea—brain cancer	0.000376	0.00673	CcSEcCtD
Zileuton—Dizziness—Procarbazine—brain cancer	0.000375	0.00673	CcSEcCtD
Zileuton—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000375	0.00524	CbGpPWpGaD
Zileuton—Myalgia—Carmustine—brain cancer	0.000371	0.00664	CcSEcCtD
Zileuton—Chest pain—Carmustine—brain cancer	0.000371	0.00664	CcSEcCtD
Zileuton—Feeling abnormal—Hydroxyurea—brain cancer	0.000362	0.00649	CcSEcCtD
Zileuton—Vomiting—Procarbazine—brain cancer	0.000361	0.00647	CcSEcCtD
Zileuton—Myalgia—Temozolomide—brain cancer	0.000358	0.00642	CcSEcCtD
Zileuton—Arthralgia—Temozolomide—brain cancer	0.000358	0.00642	CcSEcCtD
Zileuton—Rash—Procarbazine—brain cancer	0.000358	0.00642	CcSEcCtD
Zileuton—Dermatitis—Procarbazine—brain cancer	0.000358	0.00641	CcSEcCtD
Zileuton—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000357	0.00499	CbGpPWpGaD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000356	0.00498	CbGpPWpGaD
Zileuton—Headache—Procarbazine—brain cancer	0.000356	0.00637	CcSEcCtD
Zileuton—Discomfort—Temozolomide—brain cancer	0.000354	0.00634	CcSEcCtD
Zileuton—Body temperature increased—Hydroxyurea—brain cancer	0.000347	0.00623	CcSEcCtD
Zileuton—UGT1A9—Biological oxidations—CYP2C9—brain cancer	0.000345	0.00483	CbGpPWpGaD
Zileuton—UGT1A9—Metapathway biotransformation—CYP2C9—brain cancer	0.000341	0.00476	CbGpPWpGaD
Zileuton—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00034	0.00475	CbGpPWpGaD
Zileuton—Nausea—Procarbazine—brain cancer	0.000337	0.00604	CcSEcCtD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000328	0.00458	CbGpPWpGaD
Zileuton—Hypersensitivity—Hydroxyurea—brain cancer	0.000324	0.0058	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Carmustine—brain cancer	0.000324	0.0058	CcSEcCtD
Zileuton—Insomnia—Carmustine—brain cancer	0.000321	0.00576	CcSEcCtD
Zileuton—LTB4R—GPCR ligand binding—SHH—brain cancer	0.000318	0.00445	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—PTCH2—brain cancer	0.000317	0.00443	CbGpPWpGaD
Zileuton—Somnolence—Carmustine—brain cancer	0.000316	0.00566	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000313	0.0056	CcSEcCtD
Zileuton—Ill-defined disorder—Etoposide—brain cancer	0.000312	0.0056	CcSEcCtD
Zileuton—Insomnia—Temozolomide—brain cancer	0.00031	0.00556	CcSEcCtD
Zileuton—Gastrointestinal disorder—Carmustine—brain cancer	0.000307	0.0055	CcSEcCtD
Zileuton—Somnolence—Temozolomide—brain cancer	0.000305	0.00547	CcSEcCtD
Zileuton—Pain—Carmustine—brain cancer	0.000304	0.00544	CcSEcCtD
Zileuton—Constipation—Carmustine—brain cancer	0.000304	0.00544	CcSEcCtD
Zileuton—Malaise—Etoposide—brain cancer	0.000303	0.00544	CcSEcCtD
Zileuton—Dyspepsia—Temozolomide—brain cancer	0.000302	0.00542	CcSEcCtD
Zileuton—LTB4R—GPCR ligand binding—SMO—brain cancer	0.000302	0.00422	CbGpPWpGaD
Zileuton—LTB4R—GPCR ligand binding—PTCH1—brain cancer	0.000302	0.00422	CbGpPWpGaD
Zileuton—Diarrhoea—Hydroxyurea—brain cancer	0.000301	0.00539	CcSEcCtD
Zileuton—Gastrointestinal disorder—Temozolomide—brain cancer	0.000296	0.00531	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—IL2—brain cancer	0.000294	0.00411	CbGpPWpGaD
Zileuton—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000294	0.0041	CbGpPWpGaD
Zileuton—Constipation—Temozolomide—brain cancer	0.000294	0.00526	CcSEcCtD
Zileuton—Pain—Temozolomide—brain cancer	0.000294	0.00526	CcSEcCtD
Zileuton—Feeling abnormal—Carmustine—brain cancer	0.000293	0.00525	CcSEcCtD
Zileuton—LTB4R—Signaling Pathways—OR14C36—brain cancer	0.000291	0.00406	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—OR4C12—brain cancer	0.000291	0.00406	CbGpPWpGaD
Zileuton—Dizziness—Hydroxyurea—brain cancer	0.000291	0.00521	CcSEcCtD
Zileuton—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00029	0.00405	CbGpPWpGaD
Zileuton—LTB4R—Spinal Cord Injury—CCND1—brain cancer	0.000287	0.00401	CbGpPWpGaD
Zileuton—Chest pain—Etoposide—brain cancer	0.000287	0.00514	CcSEcCtD
Zileuton—UGT1A9—PPAR Alpha Pathway—CCND1—brain cancer	0.000285	0.00398	CbGpPWpGaD
Zileuton—Discomfort—Etoposide—brain cancer	0.000283	0.00507	CcSEcCtD
Zileuton—Feeling abnormal—Temozolomide—brain cancer	0.000283	0.00507	CcSEcCtD
Zileuton—PTGS1—Biological oxidations—CYP2C9—brain cancer	0.000282	0.00393	CbGpPWpGaD
Zileuton—Body temperature increased—Carmustine—brain cancer	0.000281	0.00503	CcSEcCtD
Zileuton—Vomiting—Hydroxyurea—brain cancer	0.000279	0.00501	CcSEcCtD
Zileuton—Rash—Hydroxyurea—brain cancer	0.000277	0.00497	CcSEcCtD
Zileuton—Dermatitis—Hydroxyurea—brain cancer	0.000277	0.00496	CcSEcCtD
Zileuton—Headache—Hydroxyurea—brain cancer	0.000275	0.00493	CcSEcCtD
Zileuton—LTB4R—GPCR downstream signaling—ABR—brain cancer	0.000274	0.00383	CbGpPWpGaD
Zileuton—Urticaria—Temozolomide—brain cancer	0.000273	0.00489	CcSEcCtD
Zileuton—Body temperature increased—Temozolomide—brain cancer	0.000271	0.00486	CcSEcCtD
Zileuton—Hypersensitivity—Carmustine—brain cancer	0.000262	0.00469	CcSEcCtD
Zileuton—Nausea—Hydroxyurea—brain cancer	0.000261	0.00468	CcSEcCtD
Zileuton—Hypersensitivity—Temozolomide—brain cancer	0.000253	0.00453	CcSEcCtD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000249	0.00348	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—ABR—brain cancer	0.000249	0.00348	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—DTX2—brain cancer	0.000247	0.00345	CbGpPWpGaD
Zileuton—Somnolence—Etoposide—brain cancer	0.000244	0.00438	CcSEcCtD
Zileuton—Diarrhoea—Carmustine—brain cancer	0.000243	0.00436	CcSEcCtD
Zileuton—Pruritus—Temozolomide—brain cancer	0.000243	0.00435	CcSEcCtD
Zileuton—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000238	0.00333	CbGpPWpGaD
Zileuton—Gastrointestinal disorder—Etoposide—brain cancer	0.000237	0.00425	CcSEcCtD
Zileuton—Dizziness—Carmustine—brain cancer	0.000235	0.00421	CcSEcCtD
Zileuton—Constipation—Etoposide—brain cancer	0.000235	0.00421	CcSEcCtD
Zileuton—Pain—Etoposide—brain cancer	0.000235	0.00421	CcSEcCtD
Zileuton—Diarrhoea—Temozolomide—brain cancer	0.000235	0.00421	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—MYC—brain cancer	0.00023	0.00322	CbGpPWpGaD
Zileuton—ALOX5—Selenium Micronutrient Network—RELA—brain cancer	0.00023	0.00321	CbGpPWpGaD
Zileuton—UGT1A9—PPAR Alpha Pathway—MYC—brain cancer	0.000228	0.00319	CbGpPWpGaD
Zileuton—Dizziness—Temozolomide—brain cancer	0.000227	0.00407	CcSEcCtD
Zileuton—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000227	0.00317	CbGpPWpGaD
Zileuton—Feeling abnormal—Etoposide—brain cancer	0.000226	0.00406	CcSEcCtD
Zileuton—Vomiting—Carmustine—brain cancer	0.000226	0.00405	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—EGFR—brain cancer	0.000225	0.00315	CbGpPWpGaD
Zileuton—Rash—Carmustine—brain cancer	0.000224	0.00401	CcSEcCtD
Zileuton—Dermatitis—Carmustine—brain cancer	0.000224	0.00401	CcSEcCtD
Zileuton—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000224	0.00313	CbGpPWpGaD
Zileuton—Headache—Carmustine—brain cancer	0.000223	0.00399	CcSEcCtD
Zileuton—Vomiting—Temozolomide—brain cancer	0.000218	0.00391	CcSEcCtD
Zileuton—Urticaria—Etoposide—brain cancer	0.000218	0.00391	CcSEcCtD
Zileuton—Body temperature increased—Etoposide—brain cancer	0.000217	0.00389	CcSEcCtD
Zileuton—Rash—Temozolomide—brain cancer	0.000216	0.00388	CcSEcCtD
Zileuton—Dermatitis—Temozolomide—brain cancer	0.000216	0.00388	CcSEcCtD
Zileuton—Headache—Temozolomide—brain cancer	0.000215	0.00385	CcSEcCtD
Zileuton—Nausea—Carmustine—brain cancer	0.000211	0.00378	CcSEcCtD
Zileuton—Nausea—Temozolomide—brain cancer	0.000204	0.00365	CcSEcCtD
Zileuton—Hypersensitivity—Etoposide—brain cancer	0.000202	0.00363	CcSEcCtD
Zileuton—EPHX2—Metabolism—CYP2C9—brain cancer	0.0002	0.00279	CbGpPWpGaD
Zileuton—Pruritus—Etoposide—brain cancer	0.000194	0.00348	CcSEcCtD
Zileuton—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000193	0.00269	CbGpPWpGaD
Zileuton—LTB4R—Spinal Cord Injury—TP53—brain cancer	0.000189	0.00264	CbGpPWpGaD
Zileuton—Diarrhoea—Etoposide—brain cancer	0.000188	0.00337	CcSEcCtD
Zileuton—LTB4R—Signaling Pathways—PTCH2—brain cancer	0.000187	0.00262	CbGpPWpGaD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000185	0.00259	CbGpPWpGaD
Zileuton—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000184	0.00257	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000182	0.00255	CbGpPWpGaD
Zileuton—Dizziness—Etoposide—brain cancer	0.000182	0.00326	CcSEcCtD
Zileuton—LTB4R—Signaling Pathways—HES5—brain cancer	0.000181	0.00253	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—STRADA—brain cancer	0.000176	0.00246	CbGpPWpGaD
Zileuton—Vomiting—Etoposide—brain cancer	0.000175	0.00313	CcSEcCtD
Zileuton—LTB4R—pituitary gland—brain cancer	0.000174	0.11	CbGeAlD
Zileuton—LTB4R—GPCR downstream signaling—TRPC6—brain cancer	0.000173	0.00242	CbGpPWpGaD
Zileuton—Rash—Etoposide—brain cancer	0.000173	0.0031	CcSEcCtD
Zileuton—Dermatitis—Etoposide—brain cancer	0.000173	0.0031	CcSEcCtD
Zileuton—PTGS1—Selenium Micronutrient Network—SOD2—brain cancer	0.000173	0.00241	CbGpPWpGaD
Zileuton—Headache—Etoposide—brain cancer	0.000172	0.00308	CcSEcCtD
Zileuton—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000171	0.00239	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—BSG—brain cancer	0.00017	0.00237	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—SHH—brain cancer	0.000163	0.00228	CbGpPWpGaD
Zileuton—Nausea—Etoposide—brain cancer	0.000163	0.00292	CcSEcCtD
Zileuton—LTB4R—Signaling by GPCR—TRPC6—brain cancer	0.000157	0.0022	CbGpPWpGaD
Zileuton—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.000157	0.00219	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—SMO—brain cancer	0.000155	0.00216	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—PTCH1—brain cancer	0.000155	0.00216	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—ABR—brain cancer	0.000147	0.00205	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—IDH1—brain cancer	0.000146	0.00204	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—GLI2—brain cancer	0.000142	0.00198	CbGpPWpGaD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000142	0.00198	CbGpPWpGaD
Zileuton—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	0.000139	0.00195	CbGpPWpGaD
Zileuton—LTB4R—endocrine gland—brain cancer	0.000135	0.0852	CbGeAlD
Zileuton—LTB4R—Signaling Pathways—GLI1—brain cancer	0.000133	0.00186	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000133	0.00185	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.00013	0.00182	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—VAV1—brain cancer	0.00013	0.00182	CbGpPWpGaD
Zileuton—EPHX2—pituitary gland—brain cancer	0.000128	0.0809	CbGeAlD
Zileuton—LTB4R—Signaling Pathways—SUFU—brain cancer	0.000126	0.00177	CbGpPWpGaD
Zileuton—CYP1A2—Biological oxidations—CYP2C9—brain cancer	0.000126	0.00177	CbGpPWpGaD
Zileuton—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	0.000125	0.00174	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—GFAP—brain cancer	0.000122	0.00171	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000119	0.00166	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—VAV1—brain cancer	0.000118	0.00165	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—HEY1—brain cancer	0.000116	0.00162	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—ENO2—brain cancer	0.000115	0.00161	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—DLL1—brain cancer	0.000113	0.00159	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—CYP2C9—brain cancer	0.000111	0.00155	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000108	0.00151	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—RELA—brain cancer	9.97e-05	0.00139	CbGpPWpGaD
Zileuton—PTGS1—ganglion—brain cancer	9.79e-05	0.062	CbGeAlD
Zileuton—CYP3A4—Biological oxidations—CYP2C9—brain cancer	9.76e-05	0.00136	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	9.7e-05	0.00136	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—SHH—brain cancer	9.65e-05	0.00135	CbGpPWpGaD
Zileuton—LTB4R—brain—brain cancer	9.63e-05	0.061	CbGeAlD
Zileuton—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	9.63e-05	0.00135	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—BSG—brain cancer	9.44e-05	0.00132	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—TRPC6—brain cancer	9.3e-05	0.0013	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—SMO—brain cancer	9.15e-05	0.00128	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PTCH1—brain cancer	9.15e-05	0.00128	CbGpPWpGaD
Zileuton—UGT1A9—endocrine gland—brain cancer	9.06e-05	0.0574	CbGeAlD
Zileuton—EPHX2—cerebellum—brain cancer	8.72e-05	0.0552	CbGeAlD
Zileuton—PTGS1—endothelium—brain cancer	8.44e-05	0.0534	CbGeAlD
Zileuton—LTB4R—GPCR downstream signaling—PIK3CG—brain cancer	8.25e-05	0.00115	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—IDH1—brain cancer	8.12e-05	0.00113	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	7.9e-05	0.0011	CbGpPWpGaD
Zileuton—PTGS1—blood vessel—brain cancer	7.79e-05	0.0493	CbGeAlD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	7.53e-05	0.00105	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—PIK3CG—brain cancer	7.49e-05	0.00105	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—NOTCH2—brain cancer	7.31e-05	0.00102	CbGpPWpGaD
Zileuton—EPHX2—brain—brain cancer	7.09e-05	0.0449	CbGeAlD
Zileuton—LTB4R—Signaling Pathways—VAV1—brain cancer	6.97e-05	0.000974	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	6.78e-05	0.000947	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.61e-05	0.000924	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—ENO2—brain cancer	6.42e-05	0.000897	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—HES1—brain cancer	5.99e-05	0.000838	CbGpPWpGaD
Zileuton—ALOX5—endocrine gland—brain cancer	5.94e-05	0.0376	CbGeAlD
Zileuton—UGT1A9—Metabolism—CYP2C9—brain cancer	5.91e-05	0.000825	CbGpPWpGaD
Zileuton—ALOX5—head—brain cancer	5.86e-05	0.0371	CbGeAlD
Zileuton—LTB4R—GPCR downstream signaling—IL2—brain cancer	5.81e-05	0.000811	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	5.76e-05	0.000805	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PDGFRA—brain cancer	5.71e-05	0.000798	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—SPP1—brain cancer	5.54e-05	0.000774	CbGpPWpGaD
Zileuton—ALOX5—central nervous system—brain cancer	5.35e-05	0.0339	CbGeAlD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	5.3e-05	0.000741	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PIK3CG—brain cancer	5.29e-05	0.00074	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—IL2—brain cancer	5.27e-05	0.000737	CbGpPWpGaD
Zileuton—ALOX5—cerebellum—brain cancer	5.23e-05	0.0331	CbGeAlD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	5.18e-05	0.000724	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	5.18e-05	0.000724	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—BSG—brain cancer	5.02e-05	0.000702	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—IRS2—brain cancer	5.01e-05	0.0007	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.86e-05	0.000679	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—CYP2C9—brain cancer	4.81e-05	0.000673	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—APC—brain cancer	4.43e-05	0.000618	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PIK3CG—brain cancer	4.43e-05	0.000618	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—IDH1—brain cancer	4.32e-05	0.000603	CbGpPWpGaD
Zileuton—ALOX5—brain—brain cancer	4.25e-05	0.0269	CbGeAlD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.16e-05	0.000581	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—BSG—brain cancer	4.09e-05	0.000572	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—EGFR—brain cancer	4.03e-05	0.000563	CbGpPWpGaD
Zileuton—PTGS1—telencephalon—brain cancer	3.78e-05	0.0239	CbGeAlD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.55e-05	0.000496	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—IDH1—brain cancer	3.52e-05	0.000492	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.52e-05	0.000491	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—RELA—brain cancer	3.46e-05	0.000483	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—ERBB2—brain cancer	3.44e-05	0.00048	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—ENO2—brain cancer	3.41e-05	0.000477	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—IL2—brain cancer	3.11e-05	0.000435	CbGpPWpGaD
Zileuton—PTGS1—pituitary gland—brain cancer	3.08e-05	0.0195	CbGeAlD
Zileuton—LTB4R—Signaling Pathways—CCND1—brain cancer	3.04e-05	0.000424	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CTNNB1—brain cancer	3.01e-05	0.00042	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PIK3CG—brain cancer	2.94e-05	0.000411	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.87e-05	0.000401	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—ENO2—brain cancer	2.78e-05	0.000389	CbGpPWpGaD
Zileuton—CYP1A2—endocrine gland—brain cancer	2.75e-05	0.0174	CbGeAlD
Zileuton—LTB4R—Signaling Pathways—VEGFA—brain cancer	2.65e-05	0.00037	CbGpPWpGaD
Zileuton—PTGS1—spinal cord—brain cancer	2.65e-05	0.0168	CbGeAlD
Zileuton—LTB4R—Signaling Pathways—STAT3—brain cancer	2.62e-05	0.000366	CbGpPWpGaD
Zileuton—CYP2C9—endocrine gland—brain cancer	2.61e-05	0.0165	CbGeAlD
Zileuton—LTB4R—Signaling Pathways—MYC—brain cancer	2.44e-05	0.00034	CbGpPWpGaD
Zileuton—PTGS1—endocrine gland—brain cancer	2.38e-05	0.0151	CbGeAlD
Zileuton—LTB4R—Signaling Pathways—EGFR—brain cancer	2.38e-05	0.000333	CbGpPWpGaD
Zileuton—PTGS1—head—brain cancer	2.35e-05	0.0149	CbGeAlD
Zileuton—CYP1A2—Metabolism—CYP2C9—brain cancer	2.16e-05	0.000302	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—BSG—brain cancer	2.15e-05	0.000301	CbGpPWpGaD
Zileuton—PTGS1—central nervous system—brain cancer	2.15e-05	0.0136	CbGeAlD
Zileuton—LTB4R—Signaling Pathways—TP53—brain cancer	2e-05	0.000279	CbGpPWpGaD
Zileuton—CYP3A4—endocrine gland—brain cancer	1.99e-05	0.0126	CbGeAlD
Zileuton—CYP2C9—Metabolism—IDH1—brain cancer	1.85e-05	0.000259	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—BSG—brain cancer	1.84e-05	0.000257	CbGpPWpGaD
Zileuton—CYP3A4—central nervous system—brain cancer	1.79e-05	0.0114	CbGeAlD
Zileuton—PTGS1—brain—brain cancer	1.7e-05	0.0108	CbGeAlD
Zileuton—CYP3A4—Metabolism—CYP2C9—brain cancer	1.67e-05	0.000233	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—IDH1—brain cancer	1.58e-05	0.000221	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PIK3CG—brain cancer	1.57e-05	0.000219	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.51e-05	0.000211	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ENO2—brain cancer	1.46e-05	0.000204	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—BSG—brain cancer	1.42e-05	0.000198	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.29e-05	0.00018	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PIK3CG—brain cancer	1.28e-05	0.000178	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ENO2—brain cancer	1.25e-05	0.000175	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—IDH1—brain cancer	1.22e-05	0.000171	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ENO2—brain cancer	9.65e-06	0.000135	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PIK3CG—brain cancer	6.71e-06	9.38e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PIK3CG—brain cancer	5.73e-06	8.01e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PIK3CG—brain cancer	4.43e-06	6.19e-05	CbGpPWpGaD
